Collegium Pharmaceutical (COLL) PT Raised to $36 at Piper Sandler
Tweet
Share
E-mailGet Alerts COLL Hot Sheet
Price: $31.06 +1.90%
Rating Summary:
7 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
7 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
Piper Sandler analyst David Amsellem raised the price target on Collegium Pharmaceutical (NASDAQ: COLL) to $36.00 (from $35.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
- Medtronic, Inc. (MDT) PT Lowered to $101 at Needham
- Nitto Denko (6988:JP) (NDEKY) PT Lowered to JPY3,400 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
